- Home
- CLDI vs PFAI Comparison
CLDI vs PFAI Comparison
Compare CLDI & PFAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDI
- PFAI
- Stock Information
- Founded
- CLDI 2014
- PFAI 2015
- Country
- CLDI United States
- PFAI Canada
- Employees
- CLDI N/A
- PFAI N/A
- Industry
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- PFAI Farming/Seeds/Milling
- Sector
- CLDI Health Care
- PFAI Consumer Staples
- Exchange
- CLDI Nasdaq
- PFAI Nasdaq
- Market Cap
- CLDI 20.2M
- PFAI 21.1M
- IPO Year
- CLDI N/A
- PFAI 2025
- Fundamental
- Price
- CLDI $1.62
- PFAI $1.82
- Analyst Decision
- CLDI
- PFAI
- Analyst Count
- CLDI 0
- PFAI 0
- Target Price
- CLDI N/A
- PFAI N/A
- AVG Volume (30 Days)
- CLDI 485.8K
- PFAI 274.3K
- Earning Date
- CLDI 11-11-2025
- PFAI 01-01-0001
- Dividend Yield
- CLDI N/A
- PFAI N/A
- EPS Growth
- CLDI N/A
- PFAI N/A
- EPS
- CLDI N/A
- PFAI 0.03
- Revenue
- CLDI N/A
- PFAI $3,289,862.00
- Revenue This Year
- CLDI N/A
- PFAI N/A
- Revenue Next Year
- CLDI N/A
- PFAI N/A
- P/E Ratio
- CLDI N/A
- PFAI $60.99
- Revenue Growth
- CLDI N/A
- PFAI 56.60
- 52 Week Low
- CLDI $1.51
- PFAI $1.30
- 52 Week High
- CLDI $46.68
- PFAI $4.40
- Technical
- Relative Strength Index (RSI)
- CLDI 30.80
- PFAI N/A
- Support Level
- CLDI $1.51
- PFAI N/A
- Resistance Level
- CLDI $1.68
- PFAI N/A
- Average True Range (ATR)
- CLDI 0.12
- PFAI 0.00
- MACD
- CLDI 0.13
- PFAI 0.00
- Stochastic Oscillator
- CLDI 28.38
- PFAI 0.00
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.
About PFAI Pinnacle Food Group Limited Class A Common Shares
Pinnacle Food Group Ltd is a provider of smart farming solutions focused on vertical and hydroponic farming. The company focuses on promoting sustainable food security by developing and building customized smart farming systems for customers based on the systematic integration of technology, hardware, and software, coupled with a full range of integrated supply and technical services. It sells hydroponic growing systems and technical support services to individual households and community groups, and is developing a hydroponic growing system for urban farms. Geographically, the company generates the majority revenue from Canada, followed by New Zealand.